BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11125284)

  • 1. Prognostic value of serum sialyl Lewis(a), sialyl Lewis(x) and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    Tumour Biol; 2001; 22(2):115-22. PubMed ID: 11125284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H
    J Gastroenterol; 2001 Mar; 36(3):166-72. PubMed ID: 11291879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Anticancer Res; 2002; 22(1A):451-8. PubMed ID: 12017332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
    Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
    Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in prognostic value between sialyl Lewis(a) and sialyl lewis(x) antigens in blood samples obtained from the drainage veins of the colorectal tumors.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Tagawa Y
    Cancer Lett; 2000 Oct; 159(2):159-68. PubMed ID: 10996727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in prognostic value between sialyl Lewis(a) and sialyl Lewis(x) antigen levels in the preoperative serum of gastric cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    J Clin Gastroenterol; 2002 Apr; 34(4):408-15. PubMed ID: 11907351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in release mechanisms and distributions for sialyl Le(a) and sialyl Le(x) antigens in colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Tagawa Y
    Ann Surg Oncol; 2000 May; 7(4):289-95. PubMed ID: 10819369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
    Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Tagawa Y
    Anticancer Res; 2000; 20(5C):3863-9. PubMed ID: 11268468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between circulating sialyl Tn antigen and polypoid or nonpolypoid growth characteristics in colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Tagawa Y
    J Cancer Res Clin Oncol; 2000 Sep; 126(9):542-8. PubMed ID: 11003566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
    Takahashi I; Maehara Y; Kusumoto T; Kohnoe S; Kakeji Y; Baba H; Sugimachi K
    Br J Cancer; 1994 Jan; 69(1):163-6. PubMed ID: 8286201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.